Hummingbird Bioscience
Business Services · Singapore · 51-200 Employees
View Company Info for Free
Overview
Headquarters
61 Science Park Road #06-15, Singapore, ...Revenue
$19.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Hummingbird Bioscience
Hummingbird Bioscience is an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes. Established in 2015, Hummingbird Bioscience is headquartered in Texas, United States.Explore more
Hummingbird Bioscience Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hummingbird Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Hummingbird Bioscience recently announced quarterly report
Check if Hummingbird Bioscience has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Hummingbird Bioscience
Click to see if Hummingbird Bioscience had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Hummingbird Bioscience has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Hummingbird Bioscience launches new products
Hummingbird Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Hummingbird Bioscience is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Hummingbird Bioscience
Compare insights from companies similar to Hummingbird Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hummingbird Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Hummingbird Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Hummingbird Bioscience.
Hummingbird Bioscience financials insights
Gather financial insights about Hummingbird Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series B
$25M
2021
Series C
$125M
2025
Series C
$125M
Hummingbird Bioscience Tech Stack
A closer look at the technologies used by Hummingbird Bioscience
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Hummingbird Bioscience News & Media
Hummingbird Bioscience Licenses HMBD-002, Phase II-Ready Anti-VISTA Monoclonal Antibody to Percheron Therapeutics
Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s HMBD-002 for further clinical developmentCallio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience Financing led by Frazier Life Sciences with significant participation from Jeito Capital alongside...Hummingbird Bioscience Licenses Novel Antibodies to Immunome
Hummingbird Bioscience Licenses Novel Antibodies to ImmunomeHummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024
Hummingbird Bioscience today announced a poster presentation on HMBD-802, a dual-payload ADC, at the 36th EORTC-NCI-AACR symposium.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hummingbird Bioscience
Sign Up For FreeTo access detailed company insights
Hummingbird Bioscience is an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes. Established in 2015, Hummingbird Bioscience is headquartered in Texas, United States.... Read More
